Skip to content

Change in AP at other companies

Pfizer logo
PfizerPFE
-$117.25M+54.2%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$1.21M-66.0%
Philip Morris International logo
Philip Morris InternationalPM
-$317M-150%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.

The official record: Achieve Life Sciences’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's change in AP?
Achieve Life Sciences (ACHV) reported change in AP of -$439K in Q2 2025.
How has Achieve Life Sciences's change in AP changed year-over-year?
Achieve Life Sciences's change in AP decreased by 348.0% year-over-year, from $177K to -$439K.
What is the long-term trend for Achieve Life Sciences's change in AP?
Over 2 years (2021 to 2024), Achieve Life Sciences's change in AP has grown at a 60.2% compound annual growth rate (CAGR), from $519K to $1.33M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.